Dr Rinie Bajracharya

 

Dr Rinie Bajracharya

 
 
Postdoctoral Researcher
Inflammasome Lab

 

 

Rinie completed her PhD at the Queensland Brain Institute (University of Queensland) under the supervision of Dr Rebecca Nisbet and Professor Jürgen Götz where she explored tau-specific immunotherapeutic strategies for the treatment of Alzheimer’s disease. Continuing her interest in Alzheimer’s disease, Rinie then joined the Inflammasome Lab as a Postdoctoral researcher in June 2022 where she is investigating the role of inflammasome activation in Alzheimer’s disease pathogenesis, including whether inflammasomes may be a target for therapeutic intervention.

 

"Don’t waste time taking the path that others envisage for you; instead, follow the path that makes you happy and fulfilled”

Rinie Bajracharya

 

 

CONTACTS AND LINKS

 

Email: r.bajracharya@uq.edu.au

Office Telephone: +61 7 3346 2075

 

Institute for Molecular Bioscience

ORCID

Research Gate

Twitter

LinkedIn

 

AWARDS AND PUBLICATIONS

 

 

AWARDS, GRANTS AND PRIZES

 

2016 Winter Research Scholarship, School of Biomedical Sciences, University of Queensland

2015 Dean’s Commendation for Academic Excellence, Faculty of Science, University of Queensland

2014 Dean’s Commendation for Academic Excellence, Faculty of Science, University of Queensland

 

EDUCATION

 

2022  PhD, The University of Queensland

2017  BSc Honours (First Class Honours), The University of Queensland

2016  BSc (extended major in Biomedical Science), The University of Queensland

 

 

 

 

Bajracharya R, Cruz E, Götz J, Nisbet RM (2021).
Ultrasound-mediated delivery of novel anti-tau antibody enhances brain uptake but does not enhance therapeutic efficacy. Journal of Controlled Release Sep;349:634-648. Pubmed

 

Bajracharya R, Caruso AC, Vella LJ, Nisbet RM (2021).
Current and emerging strategies for enhancing antibody delivery to the brain. Pharmaceutics Nov 26;13(12):2014. Pubmed

 

Bajracharya R, Brici D, Bodea LG, Janowicz PW, Götz J, Nisbet RM (2021).
Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice. Acta Neuropathologica Communications Mar 12;9(1):42. Pubmed